Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.
The global Erythromycin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Erythromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Erythromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Erythromycin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Erythromycin include Kelun Chuanning Biotechnology, Ercros S.A., HEC Group, Envee Drugs Pvt Ltd, Mehta Api, Abbvie, Ningxia Qiyuan, Calyx C & P and Alembic Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Erythromycin production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Erythromycin by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Erythromycin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Erythromycin, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Erythromycin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Erythromycin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Erythromycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Erythromycin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma
Segment by Type
Erythromycin Thiocyanate
Azithromycin
Clarithromycin
Roxithromycin
Others
Segment by Application
Human Medication
Veterinary Medication
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Erythromycin production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Erythromycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Erythromycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Erythromycin sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Erythromycin Product Introduction
1.2 Market by Type
1.2.1 Global Erythromycin Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Erythromycin Thiocyanate
1.2.3 Azithromycin
1.2.4 Clarithromycin
1.2.5 Roxithromycin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Erythromycin Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Human Medication
1.3.3 Veterinary Medication
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Erythromycin Production
2.1 Global Erythromycin Production Capacity (2019-2030)
2.2 Global Erythromycin Production by Region: 2019 VS 2023 VS 2030
2.3 Global Erythromycin Production by Region
2.3.1 Global Erythromycin Historic Production by Region (2019-2024)
2.3.2 Global Erythromycin Forecasted Production by Region (2025-2030)
2.3.3 Global Erythromycin Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Erythromycin Revenue Estimates and Forecasts 2019-2030
3.2 Global Erythromycin Revenue by Region
3.2.1 Global Erythromycin Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Erythromycin Revenue by Region (2019-2024)
3.2.3 Global Erythromycin Revenue by Region (2025-2030)
3.2.4 Global Erythromycin Revenue Market Share by Region (2019-2030)
3.3 Global Erythromycin Sales Estimates and Forecasts 2019-2030
3.4 Global Erythromycin Sales by Region
3.4.1 Global Erythromycin Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Erythromycin Sales by Region (2019-2024)
3.4.3 Global Erythromycin Sales by Region (2025-2030)
3.4.4 Global Erythromycin Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Erythromycin Sales by Manufacturers
4.1.1 Global Erythromycin Sales by Manufacturers (2019-2024)
4.1.2 Global Erythromycin Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erythromycin in 2023
4.2 Global Erythromycin Revenue by Manufacturers
4.2.1 Global Erythromycin Revenue by Manufacturers (2019-2024)
4.2.2 Global Erythromycin Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Erythromycin Revenue in 2023
4.3 Global Erythromycin Sales Price by Manufacturers
4.4 Global Key Players of Erythromycin, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Erythromycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Erythromycin, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Erythromycin, Product Offered and Application
4.8 Global Key Manufacturers of Erythromycin, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Erythromycin Sales by Type
5.1.1 Global Erythromycin Historical Sales by Type (2019-2024)
5.1.2 Global Erythromycin Forecasted Sales by Type (2025-2030)
5.1.3 Global Erythromycin Sales Market Share by Type (2019-2030)
5.2 Global Erythromycin Revenue by Type
5.2.1 Global Erythromycin Historical Revenue by Type (2019-2024)
5.2.2 Global Erythromycin Forecasted Revenue by Type (2025-2030)
5.2.3 Global Erythromycin Revenue Market Share by Type (2019-2030)
5.3 Global Erythromycin Price by Type
5.3.1 Global Erythromycin Price by Type (2019-2024)
5.3.2 Global Erythromycin Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Erythromycin Sales by Application
6.1.1 Global Erythromycin Historical Sales by Application (2019-2024)
6.1.2 Global Erythromycin Forecasted Sales by Application (2025-2030)
6.1.3 Global Erythromycin Sales Market Share by Application (2019-2030)
6.2 Global Erythromycin Revenue by Application
6.2.1 Global Erythromycin Historical Revenue by Application (2019-2024)
6.2.2 Global Erythromycin Forecasted Revenue by Application (2025-2030)
6.2.3 Global Erythromycin Revenue Market Share by Application (2019-2030)
6.3 Global Erythromycin Price by Application
6.3.1 Global Erythromycin Price by Application (2019-2024)
6.3.2 Global Erythromycin Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Erythromycin Market Size by Type
7.1.1 US & Canada Erythromycin Sales by Type (2019-2030)
7.1.2 US & Canada Erythromycin Revenue by Type (2019-2030)
7.2 US & Canada Erythromycin Market Size by Application
7.2.1 US & Canada Erythromycin Sales by Application (2019-2030)
7.2.2 US & Canada Erythromycin Revenue by Application (2019-2030)
7.3 US & Canada Erythromycin Sales by Country
7.3.1 US & Canada Erythromycin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Erythromycin Sales by Country (2019-2030)
7.3.3 US & Canada Erythromycin Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Erythromycin Market Size by Type
8.1.1 Europe Erythromycin Sales by Type (2019-2030)
8.1.2 Europe Erythromycin Revenue by Type (2019-2030)
8.2 Europe Erythromycin Market Size by Application
8.2.1 Europe Erythromycin Sales by Application (2019-2030)
8.2.2 Europe Erythromycin Revenue by Application (2019-2030)
8.3 Europe Erythromycin Sales by Country
8.3.1 Europe Erythromycin Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Erythromycin Sales by Country (2019-2030)
8.3.3 Europe Erythromycin Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Erythromycin Market Size by Type
9.1.1 China Erythromycin Sales by Type (2019-2030)
9.1.2 China Erythromycin Revenue by Type (2019-2030)
9.2 China Erythromycin Market Size by Application
9.2.1 China Erythromycin Sales by Application (2019-2030)
9.2.2 China Erythromycin Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Erythromycin Market Size by Type
10.1.1 Asia Erythromycin Sales by Type (2019-2030)
10.1.2 Asia Erythromycin Revenue by Type (2019-2030)
10.2 Asia Erythromycin Market Size by Application
10.2.1 Asia Erythromycin Sales by Application (2019-2030)
10.2.2 Asia Erythromycin Revenue by Application (2019-2030)
10.3 Asia Erythromycin Sales by Region
10.3.1 Asia Erythromycin Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Erythromycin Revenue by Region (2019-2030)
10.3.3 Asia Erythromycin Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Erythromycin Market Size by Type
11.1.1 Middle East, Africa and Latin America Erythromycin Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Erythromycin Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Erythromycin Market Size by Application
11.2.1 Middle East, Africa and Latin America Erythromycin Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Erythromycin Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Erythromycin Sales by Country
11.3.1 Middle East, Africa and Latin America Erythromycin Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Erythromycin Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Erythromycin Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 Kelun Chuanning Biotechnology
12.1.1 Kelun Chuanning Biotechnology Company Information
12.1.2 Kelun Chuanning Biotechnology Overview
12.1.3 Kelun Chuanning Biotechnology Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Kelun Chuanning Biotechnology Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Kelun Chuanning Biotechnology Recent Developments
12.2 Ercros S.A.
12.2.1 Ercros S.A. Company Information
12.2.2 Ercros S.A. Overview
12.2.3 Ercros S.A. Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Ercros S.A. Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ercros S.A. Recent Developments
12.3 HEC Group
12.3.1 HEC Group Company Information
12.3.2 HEC Group Overview
12.3.3 HEC Group Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 HEC Group Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 HEC Group Recent Developments
12.4 Envee Drugs Pvt Ltd
12.4.1 Envee Drugs Pvt Ltd Company Information
12.4.2 Envee Drugs Pvt Ltd Overview
12.4.3 Envee Drugs Pvt Ltd Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Envee Drugs Pvt Ltd Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Envee Drugs Pvt Ltd Recent Developments
12.5 Mehta Api
12.5.1 Mehta Api Company Information
12.5.2 Mehta Api Overview
12.5.3 Mehta Api Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Mehta Api Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Mehta Api Recent Developments
12.6 Abbvie
12.6.1 Abbvie Company Information
12.6.2 Abbvie Overview
12.6.3 Abbvie Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Abbvie Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Abbvie Recent Developments
12.7 Ningxia Qiyuan
12.7.1 Ningxia Qiyuan Company Information
12.7.2 Ningxia Qiyuan Overview
12.7.3 Ningxia Qiyuan Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Ningxia Qiyuan Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Ningxia Qiyuan Recent Developments
12.8 Calyx C & P
12.8.1 Calyx C & P Company Information
12.8.2 Calyx C & P Overview
12.8.3 Calyx C & P Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 Calyx C & P Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Calyx C & P Recent Developments
12.9 Alembic Pharma
12.9.1 Alembic Pharma Company Information
12.9.2 Alembic Pharma Overview
12.9.3 Alembic Pharma Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Alembic Pharma Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Alembic Pharma Recent Developments
12.10 SM Biomed
12.10.1 SM Biomed Company Information
12.10.2 SM Biomed Overview
12.10.3 SM Biomed Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 SM Biomed Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 SM Biomed Recent Developments
12.11 Anuh Pharma
12.11.1 Anuh Pharma Company Information
12.11.2 Anuh Pharma Overview
12.11.3 Anuh Pharma Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.11.4 Anuh Pharma Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Anuh Pharma Recent Developments
12.12 Shaoxing Hantai Pharma
12.12.1 Shaoxing Hantai Pharma Company Information
12.12.2 Shaoxing Hantai Pharma Overview
12.12.3 Shaoxing Hantai Pharma Erythromycin Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.12.4 Shaoxing Hantai Pharma Erythromycin Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Shaoxing Hantai Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Erythromycin Industry Chain Analysis
13.2 Erythromycin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Erythromycin Production Mode & Process
13.4 Erythromycin Sales and Marketing
13.4.1 Erythromycin Sales Channels
13.4.2 Erythromycin Distributors
13.5 Erythromycin Customers
14 Erythromycin Market Dynamics
14.1 Erythromycin Industry Trends
14.2 Erythromycin Market Drivers
14.3 Erythromycin Market Challenges
14.4 Erythromycin Market Restraints
15 Key Finding in The Global Erythromycin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Kelun Chuanning Biotechnology
Ercros S.A.
HEC Group
Envee Drugs Pvt Ltd
Mehta Api
Abbvie
Ningxia Qiyuan
Calyx C & P
Alembic Pharma
SM Biomed
Anuh Pharma
Shaoxing Hantai Pharma
听
听
*If Applicable.
